CN103689590B - Health food of a kind of auxiliary antilipemic and preparation method thereof - Google Patents
Health food of a kind of auxiliary antilipemic and preparation method thereof Download PDFInfo
- Publication number
- CN103689590B CN103689590B CN201310631349.0A CN201310631349A CN103689590B CN 103689590 B CN103689590 B CN 103689590B CN 201310631349 A CN201310631349 A CN 201310631349A CN 103689590 B CN103689590 B CN 103689590B
- Authority
- CN
- China
- Prior art keywords
- extract
- agar
- algin
- health food
- herb gynostemmae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013402 health food Nutrition 0.000 title claims abstract description 29
- 230000002402 anti-lipaemic effect Effects 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 229920001817 Agar Polymers 0.000 claims abstract description 28
- 235000010419 agar Nutrition 0.000 claims abstract description 28
- 241000206672 Gelidium Species 0.000 claims abstract description 25
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 25
- 229920000615 alginic acid Polymers 0.000 claims abstract description 25
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 22
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 9
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 8
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 8
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 8
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 8
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 8
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 8
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 8
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 8
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 8
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 8
- 241000196324 Embryophyta Species 0.000 claims abstract description 4
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract 4
- 241000748223 Alisma Species 0.000 claims description 15
- 235000020717 hawthorn extract Nutrition 0.000 claims description 14
- 239000012141 concentrate Substances 0.000 claims description 11
- 241001092040 Crataegus Species 0.000 claims description 7
- 241000195474 Sargassum Species 0.000 claims description 6
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 238000004108 freeze drying Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 3
- 241000206607 Porphyra umbilicalis Species 0.000 claims description 3
- 241001261505 Undaria Species 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 48
- 150000002632 lipids Chemical class 0.000 abstract description 21
- 235000012000 cholesterol Nutrition 0.000 abstract description 18
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- 150000003626 triacylglycerols Chemical class 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 14
- 239000000203 mixture Substances 0.000 abstract description 6
- 230000001603 reducing effect Effects 0.000 abstract description 6
- 230000029142 excretion Effects 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 230000003143 atherosclerotic effect Effects 0.000 abstract description 2
- 230000003516 hyperlipidaemic effect Effects 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 210000000813 small intestine Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 18
- 108010023302 HDL Cholesterol Proteins 0.000 description 12
- 108010028554 LDL Cholesterol Proteins 0.000 description 12
- 235000013305 food Nutrition 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- 235000013325 dietary fiber Nutrition 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 238000003304 gavage Methods 0.000 description 7
- 241000700159 Rattus Species 0.000 description 6
- 201000005577 familial hyperlipidemia Diseases 0.000 description 6
- 241001065361 Gynostemma Species 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 230000000996 additive effect Effects 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 4
- 241000786103 Steatomys pratensis Species 0.000 description 4
- 239000003613 bile acid Substances 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 235000021590 normal diet Nutrition 0.000 description 4
- 229960002855 simvastatin Drugs 0.000 description 4
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical group C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 208000032928 Dyslipidaemia Diseases 0.000 description 2
- 208000017170 Lipid metabolism disease Diseases 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- RNXZPKOEJUFJON-UHFFFAOYSA-N aurantio-obtusin Chemical compound CC1=C(O)C(OC)=C2C(=O)C3=C(O)C(OC)=C(O)C=C3C(=O)C2=C1 RNXZPKOEJUFJON-UHFFFAOYSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 2
- 239000005516 coenzyme A Substances 0.000 description 2
- 229940093530 coenzyme a Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 229930187479 gypenoside Natural products 0.000 description 2
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 description 2
- 235000009200 high fat diet Nutrition 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- -1 trihydroxy trimethyl glutaryl Chemical group 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- NLOAQXKIIGTTRE-JSWHPQHOSA-N Alisol b acetate Chemical compound O([C@@H]1[C@@H](OC(C)=O)C[C@@H](C)C=2CC[C@]3(C)[C@@]4(C)CC[C@H]5C(C)(C)C(=O)CC[C@]5(C)[C@@H]4[C@@H](O)CC3=2)C1(C)C NLOAQXKIIGTTRE-JSWHPQHOSA-N 0.000 description 1
- NLOAQXKIIGTTRE-UHFFFAOYSA-N Alisol-B-Monoacetat Natural products C=12CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CCC=1C(C)CC(OC(C)=O)C1OC1(C)C NLOAQXKIIGTTRE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 229940122502 Cholesterol absorption inhibitor Drugs 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 229940123934 Reductase inhibitor Drugs 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229940100228 acetyl coenzyme a Drugs 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000010235 enterohepatic circulation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- OLNTVTPDXPETLC-XPWALMASSA-N ezetimibe Chemical compound N1([C@@H]([C@H](C1=O)CC[C@H](O)C=1C=CC(F)=CC=1)C=1C=CC(O)=CC=1)C1=CC=C(F)C=C1 OLNTVTPDXPETLC-XPWALMASSA-N 0.000 description 1
- 229940125753 fibrate Drugs 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Dispersion Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of health food for auxiliary antilipemic and preparation method thereof, form primarily of following composition of raw materials: agar-agar, algin, hawthorn, gynostemma pentaphylla, rhizoma alismatis, cassia seed.The present invention is by limiting composition and the proportioning of this health food, and the preparation method of each Chinese medical extract, make it can suppress the absorption of cholesterol, promote the excretion of cholesterol and triglycerides, reduce small intestine to the absorption of lipid, thus from the multi-faceted effect reaching reducing blood lipid.In addition, all raw materials of the present invention are natural plant raw material, have that raw material sources are wide, cost is low, to advantages such as body have no side effect, effectively can reduce the blood lipid level of hyperlipemic patients, containment atherosclerotic.
Description
Technical field
The present invention relates to technical field of health care food, be specifically related to a kind of based on agar-agar, algin, take Chinese medicine as the health food of auxiliary auxiliary antilipemic, the invention still further relates to the preparation method of this health food.
Background technology
ESC 2013 (ESC2013) reports the result of dyslipidemia international research (DYSIS) China research in mid-term, although show to receive fat-reducing medicament (LLD) treatment, but still having the patient of larger proportion, there is continuation dyslipidemia in the patient that especially cardiovascular risk is higher.Result of study is pointed out, still in the urgent need to optimizing lipid-lowering therapy scheme.
Fat metabolism or running make lipids contents in blood plasma be called hyperlipemia higher than during normal range (NR) extremely.High fat of blood is the hazards that the cardiovascular disease such as coronary heart disease, myocardial infarction is the most serious.The blood fat increased can be described as " rubbish " in blood vessel, and especially LDL-C and triglycerides increase and can cause serious destruction to blood vessel, is cause coronary heart disease, the heart to obstruct " arch-criminal ".At present, lipid-regulation medicine clinically has: (1) trihydroxy trimethyl glutaryl coenzyme A (HMG-CoA) reductase inhibitor (Statins); (2) fibrate (the special class of shellfish); (3) cholic acid chelating agent; (4) nicotinic acid class; (5) selective cholesterol absorption inhibitor (clothing Ezetimibe).Though Western medicine is clinically effective soon, effect is obvious, long-term taking, drug toxicity is large, easily causes the symptoms such as stomach reaction, flush, headache, insomnia, weakness of limbs, has certain damage to liver, kidney.Traditional Chinese medicine for treating hyperlipidemia curative effect is slow, and the medication cycle is long.
Dietary fiber (dietaryfiber is called for short DF) refers to not easily digested, the general name of the macromolecular substances based on polysaccharide, the condensate be made up of materials such as cellulose, pectic substance, hemicellulose and glycoprotein.It is current a kind of functional food of generally acknowledging in the world, is called as the 7th nutrient except water, protein, carbohydrate, lipid, vitamin, the large nutrient of mineral matter six.Research shows, common atherosclerotic, hypertension, coronary heart disease, hyperlipemia are all relevant with dietary fiber intake deficiency.
The strong water absorbing capacity of dietary fiber can make the volume of ight soil in enteron aisle increase, and accelerates its transport speed, reduces the time of wherein harmful substance contact intestines wall; Lignin wherein can absorb bile acid, and pectin in conjunction with cholesterol, thus can reach minimizing intestines wall to the absorption of cholesterol, the effect of increased excretions of cholesterol metabolism, while making body inner cholesterol content decline, promotes that bile acid is discharged from ight soil.
Agar-agar and algin all belong to soluble dietary fiber, have strong absorptive, can absorb the moisture in enteron aisle, and intestinal contents is expanded, and increase stool amount; At stimulation intestines wall, while relief of constipation, be combined with cholesterol, promote cholesterol catabolism.Hawthorn, containing the composition such as vitamin C, flavones, has food digesting stomach fortifying, the stasis of blood is fallen apart in promoting the circulation of qi, changes effect of turbid lipopenicillinase; Gynostemma pentaphylla, containing the composition such as gypenoside, ginsenoside, has effect of eliminating inflammation and expelling toxin, cough-relieving apophlegmatic; Rhizoma alismatis, containing compositions such as Alisol B monoacetate, 24-acetylalisol A, has clearing damp and promoting diuresis, expels the heat-evil, changes effect of turbid lipopenicillinase; Cassia seed, containing the composition such as Chrysophanol, aurantio-obtusin, the effect there is removing heat to brighten vision, relaxing bowel.
Hawthorn, gynostemma pentaphylla, rhizoma alismatis, cassia seed, all have blood fat reducing function, extensively approved by the world of medicine.But have no dietary fiber and Chinese Medicine and Clavicular, utilize its synergy to reach the relevant report of reducing blood lipid object.Therefore, inventor is by different from Chinese medicine for dietary fiber compatibility, and the health food of exploitation auxiliary antilipemic has realistic meaning.
Summary of the invention
The medicine that the object of the invention is to utilize China traditional is theoretical, provide a kind of can the health food of auxiliary antilipemic, this health food cost is low, source is wide, have no side effect to body, has the effect reducing hyperlipemic patients blood lipid level.
The present invention is achieved through the following technical solutions:
A health food for auxiliary antilipemic, its raw material comprises agar-agar 0 ~ 70wt%, algin 0 ~ 70wt%; Also comprise Chinese medicine additive, this Chinese medicine additive adopts the Alisma extract of 0 ~ 50wt%; Wherein, the consumption lower limit of Chinese medicine additive is non-vanishing, and the consumption lower limit of agar-agar and algin is all non-vanishing.
Described agar-agar derives from fragrant plant mentioned in ancient texts, agar, Yi Guzao or laver, and described algin derives from sea-tangle, undaria pinnitafida, bulk kelp, sargassum fusifome or sargassum.
Above-mentioned Chinese medicine additive adopts the Alisma extract of 0 ~ 50wt% and the Herb Gynostemmae Pentaphylli extract of 0 ~ 50wt%; Wherein, be zero when Alisma extract is different with the consumption lower limit of Herb Gynostemmae Pentaphylli extract.
Above-mentioned Chinese medicine additive adopts the cassia seed extract of the haw thorn extract of 0 ~ 50wt%, the Herb Gynostemmae Pentaphylli extract of 0 ~ 50wt% and 0 ~ 50wt%; Wherein, haw thorn extract, Herb Gynostemmae Pentaphylli extract are zero time different with the consumption lower limit of cassia seed extract.
A preparation method for the health food of auxiliary antilipemic, mixes each raw material according to weight proportion, grinds to form smalls, incapsulate, every 0.3-0.6 gram.
The preparation method of described haw thorn extract or Alisma extract or Herb Gynostemmae Pentaphylli extract or cassia seed extract is as follows: be the ethanol water refluxing extraction 2 ~ 4 times of 0 ~ 70% by hawthorn or rhizoma alismatis or gynostemma pentaphylla or cassia seed concentration of volume percent, solid-to-liquid ratio 1:5 ~ 1:10, each 1 ~ 4h, filter and merge extract, reduced pressure concentration obtains concentrate,-80 DEG C of freeze overnight, freeze drying or spraying dry.
The present invention, compared with existing like product, has good lipid-lowering effect.Its feature is, by soluble dietary fiber and Chinese Medicine and Clavicular, effectively can play the synergy of the two.The seaweed diet fiber such as agar-agar, algin has gel characteristic, in enteron aisle, form gel, separates and detention cholesterol, affects the contact of cholesterol and digestive ferment, bile acid micelle and intestinal mucosa, thus is beneficial to the decomposition excretion of metabolism of lipid and cholesterol.Simultaneously, seaweed diet fiber directly can adsorb cholesterol (TC), triglycerides (TG) and the FBA (FBA) in enteron aisle and excrete with ight soil, the enteron aisle decreasing TC, TG and FBA absorbs again, accelerate the catabolism of cholesterol, block enterohepatic circulation of bile acid, thus serum TC, TG level are reduced.Flavones in Chinese medicine hawthorn by suppressing the activity of trihydroxy trimethyl glutaryl coenzyme A (HMG-CoA) reductase, can suppress the synthesis of endogenous cholesterol.Rhizoma alismatis can affect the decomposition of fat, reduces the synthesis of acetyl coenzyme A, thus affects the synthesis of cholesterol, and has prevention lipoids be detained in blood or penetrate into the ability of intestines inwall, promotes transport and the removing of Blood Cholesterol.Gypenoside in gynostemma pentaphylla, ginsenoside etc. can increase metabolism and the excretion of cholesterol, thus reduce blood cholesterol level.Archen in cassia seed can promote the metabolism of cholesterol.
Feature of the present invention is also, serum total cholesterol (TC), triglycerides (TG) and LDL-C (LDL-C) level can be reduced simultaneously, and increasing high density lipoprotein cholesterol (HDL-C) level, reduce arteriosclerotic risk.
Detailed description of the invention
Further describe the present invention below by way of detailed description of the invention, but the present invention is not limited only to following examples.Following examples are only limitted to be described further curative effect of the present invention.
Embodiment one
A health food for auxiliary antilipemic, its each weight percentages of components is: agar-agar 50wt%, algin 30wt%, Alisma extract 20wt%.
Embodiment two
A health food for auxiliary antilipemic, its each weight percentages of components is: agar-agar 50wt%, algin 30wt%, Alisma extract 8wt%, Herb Gynostemmae Pentaphylli extract 12wt%.Embodiment three
A health food for auxiliary antilipemic, its each weight percentages of components is: agar-agar 27wt%, algin 27wt%, haw thorn extract 18wt%, Herb Gynostemmae Pentaphylli extract 15wt%, cassia seed extract 13wt%.
Embodiment four
A health food for auxiliary antilipemic, its each weight percentages of components is: agar-agar 55%, algin 10%, haw thorn extract 15%, Herb Gynostemmae Pentaphylli extract 10%, cassia seed extract 10%.
In the present invention, agar-agar derives from fragrant plant mentioned in ancient texts, agar, Yi Guzao or laver, and algin derives from sea-tangle, undaria pinnitafida, bulk kelp, sargassum fusifome or sargassum.
The preparation method of the health food of a kind of auxiliary antilipemic of the present invention, mixes each raw material according to weight proportion, grinds to form smalls, incapsulate, every 0.3-0.6 gram.
Wherein, the preparation method of described haw thorn extract or Alisma extract or Herb Gynostemmae Pentaphylli extract or cassia seed extract is as follows: be the ethanol water refluxing extraction 2 ~ 4 times of 0 ~ 70% by hawthorn or rhizoma alismatis or gynostemma pentaphylla or cassia seed concentration of volume percent, solid-to-liquid ratio 1:5 ~ 1:10, each 1 ~ 4h, filter and merge extract, reduced pressure concentration obtains concentrate ,-80 DEG C of freeze overnight, freeze drying, is ground into powder.Or after merging extract, filtrate is condensed into the concentrate of relative density between 1.05 ~ 1.20, then uses pneumatic spray drying powdered, the inlet temperature of spray dryer 150 ~ 200 DEG C, outlet temperature 60 ~ 80 DEG C.
Pharmacodynamic observation
1. the present invention is to the reducing effect of hyperlipemia lipid of mice level.
1.1 animal subject
Kunming kind SD mouse, male, 60, body weight 20 ± 2g, is provided (credit number: SCXK (Fujian) 2005 ~ 0003) by Fuzhou Neptunus Fuyao Pharmaceuticals Co., Ltd..
The foundation of 1.2 mouse hyperlipidemia models and administration
Mouse hyperlipidemia model adopts high lipid food to cause hyperlipemia method, and high lipid food formula is as follows: 78.8% normal diet; 10.0% lard; 10.0% yolk powder; 0.2% sodium taurocholate; 1.0% cholesterol.Blank group gives normal diet, and all the other each group all gives high lipid food.
After mouse adaptability raises one week, separate 12 at random and give normal diet as blank group, all the other 48 give high lipid food, free diet drinking-water.After 10d, orbital venous plexus gets blood, measures serum total cholesterol (TC), total triglycerides (TG), HDL-C cholesterol (HDL-C), LDL-C (LDL-C) level.According to serum TC level, mouse is divided into model group, Simvastatin group, embodiment one group, embodiment two groups at random.
Mouse gavage every day 1 time, while gastric infusion, every day, free diet was drunk water, and dosage is 10mLkg
-1, successive administration 4 weeks.Each group gives following test medicine respectively:
Embodiment one group: gavage gives the compound of the health food in the embodiment of the present invention one;
Embodiment two groups: gavage gives the compound of the health food in the embodiment of the present invention two;
Simvastatin group: gavage gives the Simvastatin of Isodose;
Blank group, model group: gavage gives Isodose physiological saline;
1.3 Testing index
Detect T-CHOL (TC), triglycerides (TG), HDL-C (HDL-C) and LDL-C (LDL-C) level in serum.
1.4 experimental result
After 4 weeks, get blood, measure index of correlation, result is as table 1.
Table 1 health food of the present invention is on the impact of high fat lipid of mice
Note: contrast with model group, * P<0.05; Contrast with model group, * * P<0.01.
Table 1 shows, and embodiment one, embodiment two and Simvastatin group all can reduction high fat mouse TC, TG, LDL-C levels in various degree, raise HDL-C level.Contrast with model group, embodiment one and embodiment two all pole conspicuousness can reduce high fat mouse TC, TG, LDL-C level (P<0.01); Embodiment two extremely significantly can raise high fat mouse HDL-C level (P<0.01), and embodiment one significantly can raise high fat mouse HDL-C level (P<0.05).
As mentioned above, embodiment one and embodiment two all effectively can reduce high fat lipid of mice level, have the effect of auxiliary antilipemic.
2. the present invention is to the reducing effect of hyperlipemia Serum Lipids in Experimental HypercholesterolemicRats.
2.1 animal subject
SPF level SD rat, male, 50, body weight 200 ± 20g, is provided (credit number: SCXK (Fujian) 2005 ~ 0003) by Fuzhou Neptunus Fuyao Pharmaceuticals Co., Ltd..
The foundation of 2.2 rat hyperlipidemia models and administration
Rat adopts high lipid food to cause hyperlipemia method, and high lipid food is filled a prescription same mouse.
After adaptability raises one week, separate 10 at random and give normal diet as blank group, all the other give high lipid food, and after 1 ~ 2 week, eyeground vein clump is taken a blood sample, separation of serum, detects indices in serum.And according to TC grouping, often organize 10, totally 4 groups, be respectively: dosage group and embodiment three low dose group in model group, embodiment three high dose group, embodiment three.Rat presses 10mLkg every day
-1gavage 1 time, gives high lipid food while gavage, successive administration 4 weeks, and each group dosage is as follows:
Table 2 embodiment three high, medium and low dosage group dosage (mLkg
-1)
Blank group and model group give the physiological saline of Isodose, and high, medium and low group of embodiment three is according to table 2 gastric infusion.
2.3 Testing index
Detect T-CHOL (TC), triglycerides (TG), HDL-C (HDL-C) and LDL-C (LDL-C) level in serum.
2.4 experimental result
Table 3 embodiment three is on the impact of High fat diet rats blood fat
Note: contrast with model group, * P<0.05; Contrast with model group, * * P<0.01.
Experimental result shows, and embodiment three high dose, middle dosage group can extremely significantly reduce High fat diet rats blood lipid level.
3. conclusion
Comprehensive Experiment result, high fat of blood animal is given continuously to the present invention 30 days of various dose, each dosage group and model group contrast, and all can reduce serum total cholesterol, triglycerides and low-density lipoprotein cholesterol level, increasing high density lipoprotein cholesterol levels.
Criterion according to Ministry of Public Health's " health food inspection and assessment technical specification (2003 editions) " judges, the present invention has the effect of auxiliary antilipemic.
Claims (5)
1. a health food for auxiliary antilipemic, is characterized in that, its raw material comprises agar-agar, algin and Alisma extract, and the percentage by weight of agar-agar, algin and Alisma extract is as follows: agar-agar 50wt%, algin 30wt%, Alisma extract 20wt%;
The preparation method of the health food of described auxiliary antilipemic is: mixed according to weight proportion by each raw material, grind to form smalls, incapsulate, every 0.3-0.6 gram;
Wherein, the preparation method of described Alisma extract is as follows: be the ethanol water refluxing extraction 2 ~ 4 times of 0 ~ 70% by rhizoma alismatis concentration of volume percent, solid-to-liquid ratio 1:5 ~ 1:10, each 1 ~ 4h, filter and merge extract, reduced pressure concentration obtains concentrate ,-80 DEG C of freeze overnight, freeze drying, is ground into powder; Or after merging extract, filtrate is condensed into the concentrate of relative density between 1.05 ~ 1.20, then uses pneumatic spray drying powdered, the inlet temperature of spray dryer 150 ~ 200 DEG C, outlet temperature 60 ~ 80 DEG C.
2. the health food of a kind of auxiliary antilipemic according to claim 1, is characterized in that, described agar-agar derives from fragrant plant mentioned in ancient texts, agar, Yi Guzao or laver, and described algin derives from sea-tangle, undaria pinnitafida, bulk kelp, sargassum fusifome or sargassum.
3. the health food of an auxiliary antilipemic, it is characterized in that, its raw material comprises agar-agar, algin, Alisma extract and Herb Gynostemmae Pentaphylli extract, the percentage by weight of agar-agar, algin, Alisma extract and Herb Gynostemmae Pentaphylli extract is as follows: agar-agar 50wt%, algin 30wt%, Alisma extract 8wt%, Herb Gynostemmae Pentaphylli extract 12wt%;
The preparation method of the health food of described auxiliary antilipemic is: mixed according to weight proportion by each raw material, grind to form smalls, incapsulate, every 0.3-0.6 gram;
Wherein, the preparation method of described Alisma extract or Herb Gynostemmae Pentaphylli extract is as follows: be the ethanol water refluxing extraction 2 ~ 4 times of 0 ~ 70% by rhizoma alismatis or gynostemma pentaphylla concentration of volume percent, solid-to-liquid ratio 1:5 ~ 1:10, each 1 ~ 4h, filter and merge extract, reduced pressure concentration obtains concentrate ,-80 DEG C of freeze overnight, freeze drying, is ground into powder; Or after merging extract, filtrate is condensed into the concentrate of relative density between 1.05 ~ 1.20, then uses pneumatic spray drying powdered, the inlet temperature of spray dryer 150 ~ 200 DEG C, outlet temperature 60 ~ 80 DEG C.
4. the health food of an auxiliary antilipemic, it is characterized in that, its raw material comprises agar-agar, algin, haw thorn extract, Herb Gynostemmae Pentaphylli extract and cassia seed extract, the percentage by weight of agar-agar, algin, haw thorn extract, Herb Gynostemmae Pentaphylli extract and cassia seed extract is as follows: agar-agar 27wt%, algin 27wt%, haw thorn extract 18wt%, Herb Gynostemmae Pentaphylli extract 15wt%, cassia seed extract 13wt%;
The preparation method of the health food of described auxiliary antilipemic is: mixed according to weight proportion by each raw material, grind to form smalls, incapsulate, every 0.3-0.6 gram;
Wherein, the preparation method of described haw thorn extract or Herb Gynostemmae Pentaphylli extract or cassia seed extract is as follows: be the ethanol water refluxing extraction 2 ~ 4 times of 0 ~ 70% by hawthorn or gynostemma pentaphylla or cassia seed concentration of volume percent, solid-to-liquid ratio 1:5 ~ 1:10, each 1 ~ 4h, filter and merge extract, reduced pressure concentration obtains concentrate ,-80 DEG C of freeze overnight, freeze drying, is ground into powder; Or after merging extract, filtrate is condensed into the concentrate of relative density between 1.05 ~ 1.20, then uses pneumatic spray drying powdered, the inlet temperature of spray dryer 150 ~ 200 DEG C, outlet temperature 60 ~ 80 DEG C.
5. the health food of an auxiliary antilipemic, it is characterized in that, its raw material comprises agar-agar, algin, haw thorn extract, Herb Gynostemmae Pentaphylli extract and cassia seed extract, the percentage by weight of agar-agar, algin, haw thorn extract, Herb Gynostemmae Pentaphylli extract and cassia seed extract is as follows: agar-agar 55%, algin 10%, haw thorn extract 15%, Herb Gynostemmae Pentaphylli extract 10%, cassia seed extract 10%;
The preparation method of the health food of described auxiliary antilipemic is: mixed according to weight proportion by each raw material, grind to form smalls, incapsulate, every 0.3-0.6 gram;
Wherein, the preparation method of described haw thorn extract or Herb Gynostemmae Pentaphylli extract or cassia seed extract is as follows: be the ethanol water refluxing extraction 2 ~ 4 times of 0 ~ 70% by hawthorn or gynostemma pentaphylla or cassia seed concentration of volume percent, solid-to-liquid ratio 1:5 ~ 1:10, each 1 ~ 4h, filter and merge extract, reduced pressure concentration obtains concentrate ,-80 DEG C of freeze overnight, freeze drying, is ground into powder; Or after merging extract, filtrate is condensed into the concentrate of relative density between 1.05 ~ 1.20, then uses pneumatic spray drying powdered, the inlet temperature of spray dryer 150 ~ 200 DEG C, outlet temperature 60 ~ 80 DEG C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310631349.0A CN103689590B (en) | 2013-11-29 | 2013-11-29 | Health food of a kind of auxiliary antilipemic and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310631349.0A CN103689590B (en) | 2013-11-29 | 2013-11-29 | Health food of a kind of auxiliary antilipemic and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103689590A CN103689590A (en) | 2014-04-02 |
| CN103689590B true CN103689590B (en) | 2016-04-13 |
Family
ID=50351378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310631349.0A Active CN103689590B (en) | 2013-11-29 | 2013-11-29 | Health food of a kind of auxiliary antilipemic and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103689590B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104757464A (en) * | 2015-04-30 | 2015-07-08 | 黄馨莹 | Haw flake tablet making method |
| CN108272087A (en) * | 2018-01-30 | 2018-07-13 | 山东汇润膳食堂股份有限公司 | A kind of blood fat reducing food and preparation method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1087495A (en) * | 1993-11-16 | 1994-06-08 | 朱建华 | Low-thermal health drink and preparation method thereof |
| CN101095520A (en) * | 2006-06-26 | 2008-01-02 | 江苏晶隆海洋产业发展有限公司 | Foodstuff having lipid-lowering and slimming functions |
| CN101613378A (en) * | 2009-07-17 | 2009-12-30 | 辽宁大学 | Acidic oligosaccharide and application thereof with fat-reducing and lipid-lowering effect |
| CN101890094A (en) * | 2010-04-16 | 2010-11-24 | 新疆英惠堂生物科技有限公司 | Health care product for assisting in reducing blood fat and preparation method thereof |
| CN102246920A (en) * | 2011-08-18 | 2011-11-23 | 高益槐 | Health-care food capable of assisting in reduction of blood fat and preparation method thereof |
| CN102784254A (en) * | 2012-03-20 | 2012-11-21 | 河南九势制药股份有限公司 | Chinese medicine composition assisting in reducing blood fat and preparation method of Chinese medicine composition |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1336193A (en) * | 2000-07-31 | 2002-02-20 | 雷学军 | Antilipenic functional water containing natural medicine component and its compounding process |
-
2013
- 2013-11-29 CN CN201310631349.0A patent/CN103689590B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1087495A (en) * | 1993-11-16 | 1994-06-08 | 朱建华 | Low-thermal health drink and preparation method thereof |
| CN101095520A (en) * | 2006-06-26 | 2008-01-02 | 江苏晶隆海洋产业发展有限公司 | Foodstuff having lipid-lowering and slimming functions |
| CN101613378A (en) * | 2009-07-17 | 2009-12-30 | 辽宁大学 | Acidic oligosaccharide and application thereof with fat-reducing and lipid-lowering effect |
| CN101890094A (en) * | 2010-04-16 | 2010-11-24 | 新疆英惠堂生物科技有限公司 | Health care product for assisting in reducing blood fat and preparation method thereof |
| CN102246920A (en) * | 2011-08-18 | 2011-11-23 | 高益槐 | Health-care food capable of assisting in reduction of blood fat and preparation method thereof |
| CN102784254A (en) * | 2012-03-20 | 2012-11-21 | 河南九势制药股份有限公司 | Chinese medicine composition assisting in reducing blood fat and preparation method of Chinese medicine composition |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103689590A (en) | 2014-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101606704B (en) | Dietary fiber food with various functional actions | |
| Chu et al. | Chemical composition, antioxidant activities of polysaccharide from pine needle (Pinus massoniana) and hypolipidemic effect in high-fat diet-induced mice | |
| CN103861070B (en) | Health product for preventing angiosclerosis | |
| CN101560267B (en) | Preparation method of polysaccharide selenite | |
| CN105395919A (en) | Composition containing black fungus extract and having effect of reducing blood fat and preparation method of composition | |
| CN103211866A (en) | Soft capsule used for improving body immunity and heart and cerebral vessel function | |
| CN104799286B (en) | Composition for improving immunity and preparation method of composition | |
| CN103689590B (en) | Health food of a kind of auxiliary antilipemic and preparation method thereof | |
| CN102151284B (en) | Composition containing fucoidin sulfate and application thereof | |
| CN102640825B (en) | Lipid-lowering tea for regulating blood lipid | |
| CN1403017A (en) | Selenium-rich konjaku-green tea health food | |
| CN107375466A (en) | A kind of medicine-food two-purpose zymotic fluid with hypolipemic function and preparation method thereof | |
| CN102716414A (en) | Anti-tumor medicinal composition containing algal polysaccharide sulfate and preparation method for composition | |
| CN104288566B (en) | Traditional Chinese medicine composition for reducing cholesterol and/or reducing blood lipids as well as preparation method and application of traditional Chinese medicine composition | |
| KR101446277B1 (en) | A funcitional food increased immunity for natural drugs and method of funcitional food | |
| Jung et al. | L-ascorbic acid addition to chitosan reduces body weight in overweight women | |
| CN107594274A (en) | A kind of compound edible mushroom drink of pre- anti-cancer and preparation method thereof | |
| CN114246281A (en) | Oyster peptide and sea cucumber peptide sports flavor beverage and preparation method thereof | |
| CN103503943B (en) | Lipid-lowering biscuit and preparation method thereof | |
| CN105193993B (en) | A kind of Chinese medicine composition with blood fat reducing function and preparation method thereof and purposes | |
| CN102379904B (en) | Proteoglycan protein tablet and preparation method thereof | |
| CN103285110B (en) | Traditional Chinese medicine for treating hyperlipidemia and preparation method thereof | |
| CN102846720A (en) | Composite for lowering blood fat and improving anoxia endurance | |
| CN107375847A (en) | A kind of slimming medicine, its preparation method and application | |
| CN1280007A (en) | Jew's-ear blood fat regulating capsule |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |